3 US Penny Stocks With Market Caps Under $200M

As the U.S. stock market navigates a period of mixed performance, with tech stocks under pressure and bond yields on the rise, investors are looking for opportunities beyond the major indices. For those willing to explore smaller or newer companies, penny stocks—despite their somewhat outdated name—continue to offer intriguing possibilities. These stocks often represent affordability and growth potential, particularly when backed by solid financials.

Click here to see the full list of 743 stocks from our US Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Black Diamond Therapeutics, Inc. is a clinical-stage oncology medicine company specializing in the discovery and development of MasterKey therapies for patients with genetically defined tumors, with a market cap of $109.21 million.

Operations: Black Diamond Therapeutics, Inc. does not currently report any revenue segments.

Market Cap: $109.21M

Black Diamond Therapeutics, with a market cap of US$109.21 million, is a pre-revenue clinical-stage biotech firm focused on oncology therapies. The company maintains a strong cash position, with short-term assets of US$115.5 million surpassing both short and long-term liabilities. Despite being debt-free for five years, it remains unprofitable and has seen losses increase by 9.9% annually over the past five years. Recent earnings reports show reduced net losses compared to the previous year, indicating some financial improvement despite shareholder dilution and high volatility in its stock performance over the past year.

• Get an in-depth perspective on Black Diamond Therapeutics’ performance by reading our balance sheet health report here.

• Review our growth performance report to gain insights into Black Diamond Therapeutics’ future.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: SOPHiA GENETICS SA is a cloud-native software technology company in the healthcare sector, with a market cap of $192.01 million.